CPRX vs. QQ.L
CPRX (Catalyst Pharmaceuticals, Inc.) and QQ.L (QinetiQ Group plc) are both stocks. CPRX operates in Biotechnology (Healthcare), while QQ.L operates in Aerospace & Defense (Industrials). Over the past 10 years, CPRX returned 46.26%/yr vs 9.23%/yr for QQ.L. At a 0.08 correlation, their price movements are largely independent.
Performance
CPRX vs. QQ.L - Performance Comparison
Loading charts...
Different Trading Currencies
CPRX is traded in USD, while QQ.L is traded in GBp. To make them comparable, the QQ.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, CPRX achieves a 34.36% return, which is significantly higher than QQ.L's 7.41% return. Over the past 10 years, CPRX has outperformed QQ.L with an annualized return of 46.26%, while QQ.L has yielded a comparatively lower 9.23% annualized return.
CPRX
- 1D
- -0.03%
- 1M
- 0.64%
- YTD
- 34.36%
- 6M
- 32.77%
- 1Y
- 29.11%
- 3Y*
- 39.03%
- 5Y*
- 40.44%
- 10Y*
- 46.26%
QQ.L
- 1D
- -2.10%
- 1M
- 14.75%
- YTD
- 7.41%
- 6M
- 10.91%
- 1Y
- -6.03%
- 3Y*
- 13.28%
- 5Y*
- 7.40%
- 10Y*
- 9.23%
CPRX vs. QQ.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 34.36% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
QQ.L QinetiQ Group plc | 7.41% | 16.51% | 34.93% | -6.83% | 22.49% | -15.85% | -5.88% | 32.93% | 19.94% | -1.29% |
Correlation
The correlation between CPRX and QQ.L is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jul 11, 2007 | 0.08 |
Fundamentals
CPRX:
$3.98B
QQ.L:
£2.47B
CPRX:
$1.74
QQ.L:
-£0.14
CPRX:
6.68
QQ.L:
0.67
CPRX:
3.93
QQ.L:
4.47
CPRX:
$596.96M
QQ.L:
£3.85B
CPRX:
$378.23M
QQ.L:
£372.10M
CPRX:
$313.50M
QQ.L:
£533.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CPRX vs. QQ.L — Risk / Return Rank
CPRX
QQ.L
CPRX vs. QQ.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and QinetiQ Group plc (QQ.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CPRX | QQ.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.07 | ||
| Sortino ratioReturn per unit of downside risk | +1.46 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 0.99 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 1.52 | -0.22 | +1.75 |
| Martin ratioReturn relative to average drawdown | 3.46 | -0.46 | +3.91 |
Loading charts...
Drawdowns
CPRX vs. QQ.L - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than QQ.L's maximum drawdown of -61.16%. Use the drawdown chart below to compare losses from any high point for CPRX and QQ.L.
Loading charts...
Drawdown Indicators
| CPRX | QQ.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.25% | -61.16% | -33.09% |
Max Drawdown (1Y)Largest decline over 1 year | -19.18% | -27.17% | +7.99% |
Max Drawdown (3Y)Largest decline over 3 years | -27.29% | -32.62% | +5.33% |
Max Drawdown (5Y)Largest decline over 5 years | -45.37% | -33.81% | -11.56% |
Max Drawdown (10Y)Largest decline over 10 years | -64.87% | -43.00% | -21.87% |
Current DrawdownCurrent decline from peak | -0.03% | -16.76% | +16.73% |
Average DrawdownAverage peak-to-trough decline | -51.96% | -20.64% | -31.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.84% | 13.21% | -3.37% |
Volatility
CPRX vs. QQ.L - Volatility Comparison
The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 0.47%, while QinetiQ Group plc (QQ.L) has a volatility of 11.53%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than QQ.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CPRX | QQ.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.47% | 11.53% | -11.06% |
Volatility (6M)Calculated over the trailing 6-month period | 23.17% | 23.14% | +0.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.28% | 31.96% | +1.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.77% | 32.45% | +15.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.39% | 31.01% | +29.38% |
Dividends
CPRX vs. QQ.L - Dividend Comparison
CPRX has not paid dividends to shareholders, while QQ.L's dividend yield for the trailing twelve months is around 1.91%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQ.L QinetiQ Group plc | 1.91% | 2.00% | 1.99% | 2.49% | 2.04% | 2.59% | 2.06% | 1.84% | 2.20% | 2.60% | 2.17% | 1.99% |
Financials
CPRX vs. QQ.L - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and QinetiQ Group plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CPRX vs. QQ.L - Profitability Comparison
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.
QQ.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, QinetiQ Group plc reported a gross profit of 110.20M and revenue of 1.02B. Therefore, the gross margin over that period was 10.8%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.
QQ.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, QinetiQ Group plc reported an operating income of 110.20M and revenue of 1.02B, resulting in an operating margin of 10.8%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.
QQ.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, QinetiQ Group plc reported a net income of 69.20M and revenue of 1.02B, resulting in a net margin of 6.8%.
Frequently Asked Questions
CPRX and QQ.L have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CPRX and QQ.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer